Let's not forget that breath right which is a rival product was acquired by Gsk back in 2007 for $588m.
That's big big bucks when you consider that breath right according to clinical trials is far less effective in being able to deliver airflow into the lungs than the turbine.
So the up side is clearly huge for cgp.
